Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Rituximab May Be an Option for Refractory Polymyositis
Link ID 503
Title Rituximab May Be an Option for Refractory Polymyositis
Url http://www.medscape.com/viewarticle/565138?src=rss
Description Rituximab is safe and may be effective for adult patients with active polymyositis who are refractory to corticosteroids and at least two other immunosuppressive agents, clinicians from China conclude based on results of an open-label prospective study reported in the Journal of Rheumatology for September. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Nov 6, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Treatment and Clinical Issues in RA Management: Update From ACR 2007
  A summary of evidence supporting treatment choices and monitoring of patients with RA, as illustrated by data presented at the American College of Rheumatology 2007 Annual Meeting.
Medscape Rheumatology
Category:   Articles > Rheumatology


2. ACR 2007: Updates on Current and Emerging Biologic Response Modifiers for RA
  Explore recent advances in the pharmacologic management of rheumatoid arthritis from the American College of Rheumatology 2007 Annual Meeting. Medscape Rheumatology
Category:   Articles > Rheumatology


3. Safety and Efficacy Data on Biologic Agents for Juvenile Idiopathic Arthritis
  Update on the safety and efficacy of biologic agents for juvenile idiopathic arthritis presented at the American College of Rheumatology 2007 Scientific Meeting.
Medscape Rheumatology
Category:   Articles > Rheumatology


4. Long-Term Improvement Seen With Hip Replacement
  New study examines the effectiveness of total hip arthroplasty on long-term physical functioning
Arthritis Care Research News Alerts
Category:   Articles > Rheumatology


5. Rituximab May Be an Option for Refractory Polymyositis
  Rituximab is safe and may be effective for adult patients with active polymyositis who are refractory to corticosteroids and at least two other immunosuppressive agents, clinicians from China conclude based on results of an open-label prospective study reported in the Journal of Rheumatology for September. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS